Figure 2. Allogeneic chimerism in bone marrow recipients. Peripheral blood samples from BMT recipients were collected on Day 0, 14, 28, and 56 after BMT. Flow cytometric analysis of blood chimerism was determined using a monoclonal antibody against donor MHC class II H-2d. * p<0.05, significantly different from NS-BMT after Bonferroni’s adjustment at each time point. † p<0.05, significantly different from CYB-BMT after Bonferroni’s adjustment at each time point.